A nationwide Guillain–Barré syndrome epidemiological study in Spain during the <scp>COVID</scp> ‐19 years
The incidence of GBS in Spain is similar to that of other countries. Despite prior reports describing a significant increase in COVID-19-associated GBS in Spain, a significant drop of GBS incidence during the SARS-CoV-2 pandemic was detected, probably due to prevention measures.
Authors
- Marina Blanco‐Ruiz
- Roger Collet‐Vidiella (ORCID: https://orcid.org/0000-0003-1668-1018)
- Luís Querol (ORCID: https://orcid.org/0000-0002-4289-8264)
- Elba Pascual‐Goñi (ORCID: https://orcid.org/0000-0001-7336-4305)
- Janina Turón‐Sans (ORCID: https://orcid.org/0000-0002-8842-4646)
- Cinta Lleixà (ORCID: https://orcid.org/0000-0002-9971-0584)
- Laura Amaya‐Pascasio (ORCID: https://orcid.org/0000-0003-1162-4209)
- Laura Llansó (ORCID: https://orcid.org/0000-0003-4950-7657)
- Marta Caballero‐Ávila (ORCID: https://orcid.org/0000-0001-9850-8504)
- Álvaro Carbayo (ORCID: https://orcid.org/0000-0001-9282-8603)
- Clara Tejada‐Illa (ORCID: https://orcid.org/0009-0008-2856-7179)
- Elena Cortés
Institutions
- Hospital de Sant Pau (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Complejo Hospitalario Torrecárdenas (ES)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1111/ene.16439
- Citations
- 9
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.32
Funders
- GBS/CIDP Foundation International
- Instituto de Salud Carlos III